RESTRUCTURING EXPENSE

12 Months Ended

Dec. 31, 2011

Restructuring and Related Activities [Abstract]

Restructuring and Related Activities Disclosure [Text Block]

RESTRUCTURING EXPENSE

In the fourth quarter of 2010, the Company commenced a strategic assessment of its business and operations. This assessment focused on expanding revenue opportunities and lowering corporate overhead, including workforce and benefit reductions and facility rationalization. As a result of the execution of the strategic assessment and related restructuring plan, the Company incurred restructuring expenses of approximately $8.9 million and $3.5 million during the years ended December 31, 2011 and December 31, 2010, respectively. Restructuring expenses during the year ended December 31, 2011 consisted of approximately $4.2 million of third-party consulting costs, $1.9 million of employee severance and other benefit-related costs related to workforce reductions, $1.6 million of facility-related costs and $1.2 million of other costs. Restructuring expenses during year ended December 31, 2010 consisted of approximately $2.3 million of employee severance and other benefit-related costs related to workforce reductions and $1.2 million of third-party consulting costs.

Since inception of the strategic assessment and related restructuring plan, the Company has incurred approximately $12.4 million in total expenses, $5.4 million of third-party consulting costs, $4.2 million of employee severance and other benefit-related costs related to workforce reductions, $1.6 million of facility-related costs and $1.2 million of other costs. A large part of the third-party consulting costs and other costs were associated with the analysis of our assets and their long-term strategic value relative to other assets in which we could invest. The result of this assessment was to explore offers for the majority of the Pharmacy Services segment. Subsequent to December 31, 2011, this process culminated in an agreement providing for the sale of the Company's traditional and specialty pharmacy mail operations and community pharmacies to Walgreen Co. and certain subsidiaries. See Note 17 for further information on the agreement.

The restructuring costs are included in restructuring expense on the Consolidated Statements of Operations. As of December 31, 2011, there are restructuring accruals of $4.1 million included in accrued expenses and other current liabilities and other non-current liabilities on the Consolidated Balance Sheets. The restructuring accruals activity consisted of the following (in thousands):

	Employee Severance and Other Benefits			Consulting Costs			Facility-Related Costs			Other Costs			Total
Liability balance as of December 31, 2010	$	3,387		$	433		$	—		$	—		$	3,820
Expenses	1,888			4,228			1,592			1,177			8,885
Cash payments	(3,166		)	(4,611		)	(303		)	(531		)	(8,611		)
Liability balance as of December 31, 2011	$	2,109		$	50		$	1,289		$	646		$	4,094